(Q34138291)

31 July 2017

title

Acute effects of intramuscular and sublingual buprenorphine and buprenorphine/naloxone in non-dependent opioid abusers (English)

1 reference

31 July 2017

0 references

Angela N Duke

1

1 reference

31 July 2017

Christopher J Correia

2

1 reference

31 July 2017

Sharon L Walsh

3

1 reference

31 July 2017

George E Bigelow

4

1 reference

31 July 2017

Eric C Strain

5

1 reference

31 July 2017

publication date

25 June 2010

1 reference

31 July 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

Psychopharmacology

1 reference

31 July 2017

volume

211

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

303-312

1 reference

Relative bioavailability of different buprenorphine formulations under chronic dosing conditions

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941639

Methods for evaluating addiction liability. (A) "Attitude" of opiate addicts toward opiate-like drugs. (B) a short-term "direct" addiction test.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941639

Buprenorphine: how to use it right

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941639

Pharmacokinetics of the combination tablet of buprenorphine and naloxone

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941639

Clinical and pharmacological evaluation of buprenorphine and naloxone combinations: why the 4:1 ratio for treatment?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941639

Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941639

Effects of buprenorphine/naloxone in opioid-dependent humans

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941639

A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941639

Effects of buprenorphine versus buprenorphine/naloxone tablets in non-dependent opioid abusers

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941639

Buprenorphine and naloxone interactions in methadone maintenance patients

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941639

Sublingual buprenorphine used postoperatively: clinical observations and preliminary pharmacokinetic analysis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941639

In vivo receptor binding of the opiate partial agonist, buprenorphine, correlated with its agonistic and antagonistic actions

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941639

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941639

Sublingual versus subcutaneous buprenorphine in opiate abusers.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941639

Sublingual absorption of selected opioid analgesics

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941639

Buprenorphine alone and in combination with naloxone in non-dependent humans.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941639

Agonist and antagonist properties of buprenorphine, a new antinociceptive agent

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941639

Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941639

An oral buprenorphine and paracetamol combination compared with paracetamol alone: a single dose double-blind postoperative study

28 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-010-1898-4

Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-010-1898-4

Comparison of buprenorphine and methadone in the treatment of opioid dependence

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-010-1898-4

Sublingual buprenorphine/naloxone precipitated withdrawal in subjects maintained on 100mg of daily methadone

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941639

Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941639

Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941639

Self-administration of intravenous buprenorphine and the buprenorphine/naloxone combination by recently detoxified heroin abusers

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941639

Buprenorphine and naloxone co-administration in opiate-dependent patients stabilized on sublingual buprenorphine

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941639

Effects of agonist-antagonist opioids in humans trained in a hydromorphone/not hydromorphone discrimination.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941639

Assessment of opioid partial agonist activity with a three-choice hydromorphone dose-discrimination procedure

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941639

Buprenorphine and naloxone combinations: the effects of three dose ratios in morphine-stabilized, opiate-dependent volunteers

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941639

Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941639

Effects of buprenorphine and naloxone in morphine-stabilized opioid addicts

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941639

Bioavailability of sublingual buprenorphine

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941639

Buprenorphine and naloxone alone and in combination in opioid-dependent humans

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941639

Effects of sublingually given naloxone in opioid-dependent human volunteers

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2941639

Precipitated withdrawal by pentazocine in methadone-maintained volunteers

28 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20577717

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Buprenorphine and naloxone interactions in opiate-dependent volunteers*

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20577717

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00213-010-1898-4

1 reference

Dimensions Publication ID

31 July 2017

0 references

1 reference

31 July 2017

1 reference